Covid: First data points to Omicron re-infection risk

Prof Francois Balloux, from University College London, said: “The higher estimated re-infection ability of the Omicron variant to cause re-infection is not overly surprising and could be largely anticipated based on the large number of mutations in the spike protein carried by the omicron variant, which increase the Omicron variant’s ability to bypass host immunity.”

Source link

View More Covid: First data points to Omicron re-infection risk

MoS Health, Health News, ET HealthWorld

The National Expert Group on Vaccine Administration for COVID-19 and the National Technical Advisory Group on Immunisation are deliberating and considering scientific evidences related to vaccination of children between the age group 12 to 17 years, the Lok Sabha was informed on Friday. Minister of State for Health Bharati Pravin Pawar, in a written reply, said at present, no proposal is pending related to import of Covid vaccine for use among children and adolescents.

The National Expert Group on vaccine administration for COVID-19 (NEGVAC) and the National Technical Advisory Group on Immunisation (NTAGI) are mandated to take decisions related to offshore COVID-19 vaccine, she said.

Asked if the government has laid a roadmap to administer the Covid vaccines in children between the age group 12 to 18, the minister said, “The National Expert Group on Vaccine Administration for COVID-19 and National Technical Advisory Group on Immunization are deliberating and considering scientific evidences related to vaccination of children between the age group 12 to 17 years.”

On whether any COVID-19 vaccine for children is likely to be developed indigenously, Pawar said as of now, ZyCoV-D vaccine manufactured by Cadila Healthcare has received the approval for restricted use in emergency setting by

View More MoS Health, Health News, ET HealthWorld